Pittsboro, NC, United States of America

Michael G Evans

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 1992-2000

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael G Evans: Innovator in Cancer Treatment

Introduction

Michael G Evans is a notable inventor based in Pittsboro, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. With a total of five patents to his name, Evans has focused on creating innovative solutions that address critical health challenges.

Latest Patents

One of Evans' latest patents involves water-soluble camptothecin derivatives. This invention relates to a specific formula that includes various moieties and groups designed to enhance the efficacy of camptothecin as a topoisomerase inhibitor. The derivatives are aimed at improving the treatment of cancer by providing a more effective delivery mechanism for this important therapeutic agent.

Career Highlights

Throughout his career, Michael G Evans has worked with prominent companies in the pharmaceutical industry, including Glaxo Inc. and Glaxo Wellcome Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Evans has collaborated with notable colleagues such as Jeffrey M Besterman and Michael Luzzio. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.

Conclusion

Michael G Evans stands out as a dedicated inventor whose work in developing water-soluble camptothecin derivatives has the potential to significantly improve cancer treatment options. His contributions to the pharmaceutical industry reflect a commitment to innovation and the betterment of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…